Tuesday, September 27, 2016

Blockbuster biotech deal coming?

CNBC's Meg Tirrell reports the latest on Gilead. Geoff Porges, Leerink Partners managing director and senior biotech analyst, weighs in.

from Mergers and Acquisitions http://ift.tt/2dqrkrk

No comments:

Post a Comment